AnGes, Inc. (TYO:4563)
Japan · Delayed Price · Currency is JPY 57.00
-1.00 (-1.72%)
Apr 17, 2026, 3:30 PM JST
AnGes Market Cap
AnGes has a market cap or net worth of 22.55 billion as of April 17, 2026. Its market cap has increased by 13.03% in one year.
Market Cap
22.55B
Enterprise Value
20.72B
Revenue
874.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
57.00
Market Cap Chart
Since September 25, 2002, AnGes's market cap has decreased from 23.36B to 22.55B, a decrease of -3.47%. That is a compound annual growth rate of -0.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 22.55B | -4.61% |
| Dec 30, 2025 | 23.64B | 57.68% |
| Dec 30, 2024 | 14.99B | 5.37% |
| Dec 29, 2023 | 14.23B | -31.96% |
| Dec 30, 2022 | 20.91B | -64.42% |
| Dec 30, 2021 | 58.78B | -64.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Japan Tissue Engineering | 24.65B |
| Stella Pharma | 24.27B |
| RaQualia Pharma | 22.27B |
| Renascience | 19.54B |
| StemRIM | 19.49B |
| ReproCELL | 17.11B |
| CanBas | 14.22B |
| Immuno-Biological Laboratories | 14.06B |